Amgen Oncology lit up the Southern California sky on Myeloma on Monday, March 5 in honor of Multiple Myeloma Awareness month. The event launched their Spotlight on Myeloma for 2018 with a walk and keynote speaker myeloma patient Brian Hedford sharing his experience as a myeloma patient.
Amgen generously donated $25,000 to each myeloma foundation including the Myeloma Crowd, IMF, MMRF and LLS and will shine the burgundy beacon every evening during the month of March.
Thank you Amgen for supporting the Myeloma Crowd and promoting myeloma awareness! You can follow the @Amgen Twitter handle and #spotlightmyelomatakeover to learn more about how the Myeloma Crowd is helping to support myeloma patients on March 15.
You can support myeloma awareness in March by sharing any article on the Myeloma Crowd site on social media and by joining the Myeloma Crowd Research Initiative.
Amgen Oncology lit up the Southern California sky on Myeloma on Monday, March 5 in honor of Multiple Myeloma Awareness month. The event launched their Spotlight on Myeloma for 2018 with a walk and keynote speaker myeloma patient Brian Hedford sharing his experience as a myeloma patient.
Amgen generously donated $25,000 to each myeloma foundation including the Myeloma Crowd, IMF, MMRF and LLS and will shine the burgundy beacon every evening during the month of March.
Thank you Amgen for supporting the Myeloma Crowd and promoting myeloma awareness! You can follow the @Amgen Twitter handle and #spotlightmyelomatakeover to learn more about how the Myeloma Crowd is helping to support myeloma patients on March 15.
You can support myeloma awareness in March by sharing any article on the Myeloma Crowd site on social media and by joining the Myeloma Crowd Research Initiative.
about the author
Jennifer Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.